Skip to main content
SpringerLink
Log in

Inhibition of thrombin activity by prothrombin activation fragment 1.2

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Prothrombin is the precursor of thrombin, the central enzyme in coagulation. Prothrombin is activated in vivo by the prothrombinase complex to form fragment 1.2 and thrombin. Fragment 1.2 has an amino-terminal gla domain and two kringle domains. The second kringle domain (kringle 2) binds to the exosite II on thrombin. Nascent thrombin generated on platelet surface remains non-covalently bound to fragment 1.2 by kringle 2-exosite II interaction. To determine whether this interaction can modulate coagulant activity of thrombin, we labeled thrombin at the active site with fluorescein-Phe-Pro-Arg chloromethylketone and monitored the fluorescence changes upon ligand binding. Anionic phospholipid-bound fragment 1.2 and fragment 2 bound to FPR-thrombin and induced changes in the active site with half maximal effects at 7.2 μM and 8.8 μM, respectively. We also tested the effect of anionic phospholipid-bound fragment 1.2 (0–10 μM) on thrombin clotting activity. Phospholipid-bound fragment 1.2 inhibited fibrinogen clotting in a concentration-dependent manner but had no significant effect on amidolytic activity towards S2238, suggesting a competitive inhibition of the fibrinogen binding site. Furthermore, fragment 1.2 inhibited FPR-thrombin binding to platelet. Consistent with these findings fragment 1.2 inhibited thrombin-induced aggregation of gel filtered platelets in a concentration-dependant manner. These results suggest that the membrane-bound prothrombin fragment 1.2 may play a role in hemostasis by down regulating the procoagulant activity of newly formed thrombin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Krishnaswamy S, Nesheim ME, Pryzdial EL, Mann KG (1993) Assembly of prothrombinase complex. Methods Enzymol 222:260–280

    PubMed  CAS  Google Scholar 

  2. Mann KG, Krishnaswamy S, Lawson JH (1992) Surface-dependent hemostasis. Semin Hematol 29(3):213–226

    PubMed  CAS  Google Scholar 

  3. Pearce KH, Hof M, Lentz BR, Thompson NL (1993) Comparison of the membrane binding kinetics of bovine prothrombin and its fragment 1. J Biol Chem 268(31):22984–22991

    PubMed  CAS  Google Scholar 

  4. Arni RK, Padmanabhan K, Padmanabhan KP, Wu TP, Tulinsky A (1994) Structure of the non-covalent complex of prothrombin kringle 2 with PPACK-thrombin. Chem Phys Lipids 67–68:59–66

    Article  PubMed  Google Scholar 

  5. Jakubowski HV, Kline MD, Owen WG (1986) The effect of bovine thrombomodulin on the specificity of bovine thrombin. J Biol Chem 261(8):3876–3882

    PubMed  CAS  Google Scholar 

  6. Liu LW, Rezaie AR, Carson CW, Esmon NL, Esmon CT (1994) Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation. J Biol Chem 269(16):11807–11812

    PubMed  CAS  Google Scholar 

  7. Krishnaswamy S, Mann KG, Nesheim ME (1986) The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J Biol Chem 261(19):8977–8984

    PubMed  CAS  Google Scholar 

  8. Miletich JP, Jackson CM, Majerus PW (1978) Properties of the factor Xa binding site on human platelets. J Biol Chem 253(19):6908–6916

    PubMed  CAS  Google Scholar 

  9. Stevens WK, Nesheim ME (1993) Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin. Biochemistry 32(11):2787–2794

    Article  PubMed  CAS  Google Scholar 

  10. Wu JR, Zhou C, Majumder R, Powers DD, Weinreb G, Lentz BR (2002) Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes. Biochemistry 41(3):935–949

    Article  PubMed  CAS  Google Scholar 

  11. Fredenburgh JC, Stafford AR, Weitz JI (1997) Evidence for allosteric linkage between exosites 1 and 2 of thrombin. J Biol Chem 272(41):25493–25499

    Article  PubMed  CAS  Google Scholar 

  12. Kazal LA, Amsel S, Miller OP, Tocantins LM (1963) The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med 113:989–994

    PubMed  CAS  Google Scholar 

  13. Martinez J, Holburn RR, Shapiro SS, Erslev AJ (1974) Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. J Clin Invest 53(2):600–611

    Article  PubMed  CAS  Google Scholar 

  14. Bock PE (1988) Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-d-Phe-Pro-Arg-CH2Cl. Biochemistry 27(17):6633–6639

    Article  PubMed  CAS  Google Scholar 

  15. Timmons S, Hawiger J (1989) Isolation of human platelets by albumin gradient and gel filtration. Methods Enzymol 169:11–21

    PubMed  CAS  Google Scholar 

  16. Gitel SN, Owen WG, Esmon CT, Jackson CM (1973) A polypeptide region of bovine prothrombin specific for binding to phospholipids. Proc Natl Acad Sci USA 70(5):1344–1348

    Article  PubMed  CAS  Google Scholar 

  17. Stubbs MT, Bode W (1995) The clot thickens: clues provided by thrombin structure. Trends Biochem Sci 20(1):23–28

    Article  PubMed  CAS  Google Scholar 

  18. Tulinsky A (1996) Molecular interactions of thrombin. Semin Thromb Hemost 22(2):117–124

    Article  PubMed  CAS  Google Scholar 

  19. Li CQ, Vindigni A, Sadler JE, Wardell MR (2001) Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin. J Biol Chem 276(9):6161–6168

    Article  PubMed  CAS  Google Scholar 

  20. De Cristofaro R, De Candia E, Landolfi R, Rutella S, Hall SW (2001) Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. Biochemistry 40(44):13268–13273

    Article  PubMed  CAS  Google Scholar 

  21. Celikel R, McClintock RA, Roberts JR et al (2003) Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science 301(5630):218–221

    Article  PubMed  CAS  Google Scholar 

  22. Naski MC, Fenton JW 2nd, Maraganore JM, Olson ST, Shafer JA (1990) The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. J Biol Chem 265(23):13484–13489

    PubMed  CAS  Google Scholar 

  23. Rydel TJ, Yin M, Padmanabhan KP et al (1994) Crystallographic structure of human gamma-thrombin. J Biol Chem 269(35):22000–22006

    PubMed  CAS  Google Scholar 

  24. Anderson PJ, Nesset A, Dharmawardana KR, Bock PE (2000) Characterization of proexosite I on prothrombin. J Biol Chem 275(22):16428–16434

    Article  PubMed  CAS  Google Scholar 

  25. Ye J, Liu LW, Esmon CT, Johnson AE (1992) The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem 267(16):11023–11028

    PubMed  CAS  Google Scholar 

  26. Liu LW, Vu TK, Esmon CT, Coughlin SR (1991) The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem 266(26):16977–16980

    PubMed  CAS  Google Scholar 

  27. Gan ZR, Li Y, Chen Z, Lewis SD, Shafer JA (1994) Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J Biol Chem 269(2):1301–1305

    PubMed  CAS  Google Scholar 

  28. Sheehan JP, Sadler JE (1994) Molecular mapping of the heparin-binding exosite of thrombin. Proc Natl Acad Sci USA 91(12):5518–5522

    Article  PubMed  CAS  Google Scholar 

  29. Pospisil CH, Stafford AR, Fredenburgh JC, Weitz JI (2003) Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. J Biol Chem 278(24):21584–21591

    Article  PubMed  CAS  Google Scholar 

  30. Cote HC, Huntsman DG, Wu J, Wadsworth LD, MacGillivray RT (1997) A new method for characterization and epitope determination of a lupus anticoagulant-associated neutralizing antiprothrombin antibody. Am J Clin Pathol 107(2):197–205

    PubMed  CAS  Google Scholar 

  31. Hackeng TM, Tans G, Koppelman SJ, de Groot PG, Rosing J, Bouma BN (1996) Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin. Biochem J 319(Pt 2):399–405

    PubMed  CAS  Google Scholar 

  32. Doyle MF, Mann KG (1990) Multiple active forms of thrombin. IV Relative activities of meizothrombins. J Biol Chem 265(18):10693–10701

    PubMed  CAS  Google Scholar 

  33. Liaw PC, Fredenburgh JC, Stafford AR, Tulinsky A, Austin RC, Weitz JI (1998) Localization of the thrombin-binding domain on prothrombin fragment 2. J Biol Chem 273(15):8932–8939

    Article  PubMed  CAS  Google Scholar 

  34. Martin PD, Malkowski MG, Box J, Esmon CT, Edwards BF (1997) New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK. Structure 5(12):1681–1693

    Article  PubMed  CAS  Google Scholar 

  35. De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R (2001) Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 276(7):4692–4698

    Article  PubMed  Google Scholar 

  36. Ofosu FA, Cerskus AL, Hirsh J, Smith LM, Modi GJ, Blajchman MA (1984) The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor. Br J Haematol 57(2):229–238

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by a grant from Veterans Affairs Research Service.

Author information

Authors and Affiliations

  1. Department of Pathology and Medicine (Thrombosis Research), Baylor College of Medicine, Michael E. DeBakey VA Medical Center, MS # 150, 2002 Holcombe Blvd, Houston, TX, 77030, USA

    Swapan Kumar Dasgupta & Perumal Thiagarajan

Authors
  1. Swapan Kumar Dasgupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Perumal Thiagarajan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Swapan Kumar Dasgupta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dasgupta, S.K., Thiagarajan, P. Inhibition of thrombin activity by prothrombin activation fragment 1.2. J Thromb Thrombolysis 24, 157–162 (2007). https://doi.org/10.1007/s11239-007-0018-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-007-0018-8

Keywords

Search

Navigation